PDJE:PA:PA- (EUR)

ETF | Others |

Last Closing

USD 35.39

Change

-0.05 (-0.13)%

Market Cap

USD 0.09B

Volume

355.00
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JPX4:PA Amundi Index Solutions - Amund..

-0.06 (-0.13%)

USD 66.11B
SPY5:PA SPDR® S&P 500 UCITS ETF EUR

+1.60 (+0.31%)

USD 11.38B
WRD:PA HSBC ETFs Public Limited Compa..

+0.10 (+0.31%)

USD 9.27B
MEUD:PA Amundi Stoxx Europe 600 UCITS ..

-0.65 (-0.27%)

USD 7.87B
EQQQ:PA Invesco EQQQ NASDAQ-100 UCITS ..

+2.15 (+0.48%)

USD 7.42B
HHH:PA HSBC ETFs Public Limited Compa..

+0.15 (+0.30%)

USD 6.91B
WLD:PA Lyxor UCITS MSCI World D-EUR

+1.16 (+0.35%)

USD 6.48B
LCWD:PA Multi Units Luxembourg - Lyxor..

+0.05 (+0.27%)

USD 5.45B
SP5C:PA Lyxor S&P 500 UCITS ETF - C-EU..

+1.46 (+0.40%)

USD 4.39B
500U:PA Amundi Index Solutions - Amund..

+0.53 (+0.50%)

USD 4.29B

ETFs Containing PDJE:PA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.03% 70% C- 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 12.03% 69% C- 74% C
Trailing 12 Months  
Capital Gain 20.68% 72% C 81% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.68% 71% C- 80% B-
Trailing 5 Years  
Capital Gain 69.78% 77% C+ 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 69.78% 76% C+ 79% B-
Average Annual (5 Year Horizon)  
Capital Gain 11.35% 73% C 70% C-
Dividend Return 11.35% 72% C 68% D+
Total Return N/A 70% C- 76% C+
Risk Return Profile  
Volatility (Standard Deviation) 12.62% 58% F 75% C
Risk Adjusted Return 90.00% 92% A 93% A
Market Capitalization 0.09B 30% F 44% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.